Accendra Health, Inc. (ACCH)
OTCMKTS · Delayed Price · Currency is USD
0.0204
+0.0009 (4.62%)
At close: Nov 20, 2026
Accendra Health Stock Forecast
OTC-ACCH's stock price has decreased by -99.25% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, Accendra Health stock has a consensus rating of "Sell" and an average price target of $1.40. The average 1-year stock price forecast is 6,762.75% higher than the current stock price, while the lowest is $1.30 (+6,272.55%) and the highest is $1.50 (+7,252.94%).
Price Target: $1.40 (+6,762.75%)
Analyst Consensus: Sell
Price Target
ChartAnalyst Ratings
The average analyst rating for Accendra Health stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 4 | 3 | 3 | 1 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 5 | 3 |
Financial Forecast
Revenue This Year
2.48B
from 2.76B
Decreased by -10.11%
Revenue Next Year
2.56B
from 2.48B
Increased by 3.08%
EPS This Year
-0.69
from 1.01
EPS Next Year
-0.30
from -0.69
EPS and Forward PE are based on non-GAAP adjusted numbers.